Results: Out of 120 patients, majority 46 (38.33) had atrophic endometrium, endometrial hyperplasia in 28 (23.66%) out of which 22 had simple hyperplasia and 6 had atypical hyperplasia, endometrial polyp in 4 (3.33%) and two cases was confirmed as endometrial carcinoma on Histopathological examination. Majority of patients (40%) had ET <4mm. and 12 patient had ET >10mm. In Patient with normal and atrophic histopathology, majority had ET <4 mm and those with hyperplasia had ET>4 and with polyp ET>6mm. No case of polyp and endometrial cancer was diagnosed at ET <6mm. Conclusion: Role of endometrial thickness cannot be ignored for detecting patients at high risk especially with co-morbid conditions. Histopathological evaluation is mandatory for ruling out malignancy is selected cases of post menopausal bleeding (PMB).
Introduction
Permanent Cessation of menstruation with loss of ovarian follicular activity is called menopaus 1 . Bleeding that occurs 12 months after the last menstrual period is labeled as postmenopausal bleeding (PMB). The incidence of menopausal bleeding is around 3% and require prompt and thorough evaluation. The main aim was to rule out endometrial pathology (Carcinoma and atypical hyperplasia). The Screening modalities for endometrial cancer include, TVS, saline infusion sonography, 3-D color Doppler, Ultrasound, hysteroscopy and endometrial biopsy. In the present study, non-invasive TVS, and endometrial biopsy by minimally invasive technique endometrial aspiration and dilatation and curettage has been used for evaluation of endometrial pathology in Patient with post menopausal bleeding. 13. Bilateral Adnexa Endometrium and cavity were considered normal if TVS showed a hyperechoic line in midline of the uterus with a homogenous endometrial lining with distinct margins. Endometrial cancer was suspected in presence of heterogenous endometrium with irregular interface between endometrium and myometrium with or without fluid collection. In invasive cancer subendometrial halo is lost. The findings were noted and Patients were scheduled for D&C/endometrial aspiration after pre-anesthetic checkup. The Histopathological pattern was analysed. All the above data were compiled and statistically analysed.
Result 120 patients presenting with a post-menopausal bleeding in OPD and labour room, after apply both inclusion and exclusion criteria were enrolled in present study. Majority of patients (40%) had ET <4mm. 12 patient had ET >10mm. Majority (38.33%) of patients had atrophic endometrium and normal endometrium (10%) on Histopathological examination. Endometrial hyperplasia was detected in 28 (23.33%) out of which 22 had simple hyperplasia and 6 had atypical hyperplesia. Endometrial malignancy was detected in 16 (13.13%) patients. Out of 16 cases of endometrial malignancy, two cases were confirmed as endometrial adenocarcinoma on Histopathological after polypectomy/ hysterectomy. In Patient with normal and atrophic histopathology, majority had ET <4 mm and those with hyperplasia had ET>4mm and with polyp ET>6mm. No case of polyp and endometrial cancer was diagnosed at ET <6mm. Table: 1 Distribution of cases according to endometrial thickness on TVS (n=120).
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Conclusion
Evaluation of PMB at the earliest is essential for diagnosing endometrial status for early intervention. Role of endometrial thickness cannot be undermined for detecting patients at high risk especially with co-morbid conditions. Histopathological evaluation is mandatory for ruling out malignancy in PMB. TVS can be considered as a first line modality in the management of cases of PMB.
